FDA Alerts

FDA Alerts
FDA Alerts
Potential Therapy for Duchenne MD Gets FDA's Rare Pediatric Disease Designation
08/24/2015
The FDA has granted Rare Pediatric Disease Designation for the medication, a therapy for patients with Duchenne muscular dystrophy who are open to skipping exon 51.
08/24/2015
FDA Alerts
FDA Alerts
U.S. FDA approves 'female Viagra' with strong warning
08/19/2015
...
08/19/2015
Sexual Dysfunction
Sexual Dysfunction
FDA Approves First Drug for Hypoactive Sexual Desire Disorder in Women
08/19/2015
The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.
08/19/2015
FDA Alerts
FDA Alerts
FDA warns makers of superbug-prone scopes over testing violations
08/18/2015
By Reuters Staff ...
08/18/2015
FDA Alerts
FDA Alerts
FDA approves use of opioid painkiller in 11-16 year olds
08/17/2015
<p>The U.S. Food and Drug Administration has approved the use of opioid painkiller OxyContin in patients aged 11 to 16 who have not benefited enough from alternatives.</p>
08/17/2015
Obesity
Obesity
FDA: Temporary Balloon Device Effectively Treats Obesity
08/04/2015
The FDA has approved a new balloon device for the treatment of obesity without invasive surgery.
08/04/2015
FDA Roundup
FDA Roundup
Key FDA Approvals Include First OTC, Nonprescription Daily Oral Contraceptive, First Monoclonal Injection to Prevent RSV in Infants, and More
07/28/2015
Anthony Calabro, MA
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...
07/28/2015
Skin Cancer
Skin Cancer
FDA Approves First PCSK9 Inhibitor, New Drug for Basal Cell Carcinoma, and More
07/27/2015
The FDA has approved new options for basal cell carcinoma, HIV diagnosis, and high cholesterol that clinicians should be aware of.
07/27/2015
Mental Health Disorders
Mental Health Disorders
FDA Roundup: New Options for Depression, Schizophrenia, Lung Cancer
07/14/2015
The FDA has approved new options for major depressive disorder, schizophrenia, and metastatic non-small cell lung cancer, that clinicians should be aware of.
07/14/2015
cardiovascular disease
cardiovascular disease
FDA Strengthens NSAID Cardiovascular Warnings
07/10/2015
The FDA has decided to strengthen existing cardiovascular warnings on the labels of prescription non-aspirin nonsteroidal anti-inflammatory drugs.
07/10/2015